BGIM
SCMP

Brandywine Global Investment Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Brandywine Global Investment Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-78,107
Closed -$1.4M – 979
2017
Q4 		$1.4M Sell
78,107
-18,393
-19% -$226K 0.01% 565
2017
Q3 		$1.14M Sell
96,500
-3,942
-4% -$44.2K 0.01% 583
2017
Q2 		$1.05M Sell
100,442
-20,102
-17% -$205K 0.01% 603
2017
Q1 		$1.33M Buy
120,544
+56,296
+88% +$653K 0.01% 587
2016
Q4 		$871K Sell
64,248
-28,838
-31% -$402K 0.01% 596
2016
Q3 		$1.15M Sell
93,086
-554
-0.6% -$6.53K 0.01% 583
2016
Q2 		$1.03M Sell
93,640
-22,429
-19% -$251K 0.01% 587
2016
Q1 		$1.27M Sell
116,069
-17,681
-13% -$223K 0.01% 568
2015
Q4 		$2.31M Buy
133,750
+125,930
+1,610% +$2.26M 0.01% 540
2015
Q3 		$156K Hold
7,820
– – ﹤0.01% 740
2015
Q2 		$129K Buy
+7,820
New +$136K ﹤0.01% 782

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Brandywine Global Investment Management's SCMP Position: Q1 2018 in Review

Brandywine Global Investment Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 78,107 shares — an estimated $1.4M sold.

Brandywine Global Investment Management first reported a position in SCMP in Q2 2015 and held it in 11 quarters. The position peaked at $2.31M in Q4 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Brandywine Global Investment Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Brandywine Global Investment Management sold 78,107 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.4M.
  • Brandywine Global Investment Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2015 and held it in 11 quarters.
  • Brandywine Global Investment Management's Sucampo Pharmaceuticals, Inc. position peaked at $2.31M in Q4 2015.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Brandywine Global Investment Management's 13F filing for Q1 2018, filed 15 May 2018.